Jessner-Kanof lymphocytic infiltration of the skin associated with glatiramer acetate

Abstract

Glatiramer acetate (GLAT) is a well tolerated and safe immunomodulatory drug for the treatment of relapsing=remitting multiple sclerosis. The most commonly recognized side effects are localized injection site reactions consisting of pain, pruritus, mild erythema and induration, which sometimes persist for several days. We describe the first case of a biopsy-proven lymphocytic infiltration (T-cell pseudolymphoma) with the clinical appearance of a figured erythema on the ventrolateral thighs in the first four weeks under GLAT treatment, resolving without any evidence of recurrence despite ongoing therapy. A T-cell pseudolymphoma is a very rare side effect of GLAT treatment. For clinical purposes it is important to state that re-exposition after GLAT-induced pseudolymphoma is possible without permanent sequelae.

Keywords

glatiramer acetate infiltration Jessner-Kanof lymphocytic infiltration multiple sclerosis pseudolymphoma side effect

Get full access to this article

View all access options for this article.

References

Cerio R , Oliver GF , Jones EW , Winkelmann RK. The heterogeneity of Jessner’s lymphocytic infiltration of the skin. Immunohistochemical studies suggesting one form of perivascular lymphocytoma . J Am Acad Dermatol 1990; 23: 63-67 .

Toonstra J , Wildschut A , Boer J , Smeenk G , Willemze R , van der Putte SC et al. Jessner’s lymphocytic infiltration of the skin. A clinical study of 100 patients . Arch Dermatol 1989; 125: 1525-1530 .

Braun-Falco O , Plewig G , Wolff HH. Dermatologie und Venerologie, fourth edition. Heidelberg: Springer Verlag , 1996: 1392-1393.

Jessner M , Kanof B. Lymphocytic infiltration of the skin . Arch Dermatol Syphiol 1953; 68: 447-449 .

Liu V , McKee PH. Cutaneous T-cell lymphoproliferative disorders: approach for the surgical pathologist: recent advances and clarification of confused issues . Adv Anat Pathol 2002; 9: 79-100 .

Kalimo K , Rasanen L , Aho H , Maki J , Mustikkamki UP , Rantala I. Persistent cutaneous pseudolymphoma after intradermal gold injection . J Cutan Pathol 1996; 23: 328-334 .

Rijlaarsdam U , Scheffer E , Meijer CJ , Kruyswijk MR , Willemze R. Mycosis fungoides-like lesions associated with phenytoine and carbamazepine therapy . J Am Acad Dermatol 1991; 24: 216-220 .

Stavrianeas NG , Katoulis AC , Kanelleas A , Hatziolou E , Georgala S. Papulonodular lichenoid and pseudolymphomatous reaction at the injection site of hepatitis B virus vaccination . Dermatology 2002; 205: 166-168 .

Fridkis-Hareli M et al. Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen presenting cells: specificity and promiscuity . Proc Natl Acad Sci 1994; 91: 4872-4876 .

10.

Duda PW , Schmied MC , Cook SL , Krieger JI , Hafler DA. Glatiramer acetate (Copaxone) induces degenerate th2 polarized immune responses in patients with multiple sclerosis . J Clin Invest 2000; 105: 967-976 .

11.

Aharoni R , Teitelbaum D , Sela M , Arnon R. Bystander suppression of experimental autoimmune encephalomyelitis by T-cell lines and clones of the Th2 type induced by copolymer 1 . J Neuroimmunol 1998; 91: 135-146 .

12.

Johnson KP , Brooks BR , Cohen JA , Ford CC , Goldstein J , Lisak RP et al. and the Copolymer 1 Multiple sclerosis Study Group. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicenter, double-blind, placebo-controlled trial . Neurology 1995; 45: 1268-1276 .

13.

Schiller PI , Flaig MJ , Puchta U , Kind P , Sander CA. Detection of clonal T-cells in lichen planus . Arch Dermatol Res 2000; 292: 568-569 .

14.

Gaudez C , Regnier S , Aractingi S , Heinzlef O. Livedo-like dermatitis (Nicolau’s syndrome) after injection of copolymer-1 (glatiramer acetate) . Rev Neurol 2003; 159: 571-573 .

15.

Hofstadt U , Leclaire J , Raguz JM , Hilker O , Haneke E , Jörg J. Delayed-type hypersensitivity to glatiramer acetate (Copaxone): report of three cases . J Neurol 1999; 245: 418-418 .

16.

Windhagen A , Maniak S , Marckmann S , Lindert RB , Heidenreich F , Blasczyk R. Lymphadenopathy in patients with multiple sclerosis undergoing treatment with glatiramer acetate . J Neurol Neurosurg Psychiatry 2001; 70: 415-416 .